Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of Risk Minimization Measures: A Survey Among Pharmacists to Assess the Impact of the RMP Material for Patients on Promoting the Proper Use of NINLARO in Japan

NCT05882279 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05882279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of Risk Minimization Measures: A Survey Among Pharmacists to Assess the Impact of the RMP Material for Patients on Promoting the Proper Use of NINLARO in Japan
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
June 9, 2023
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma